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Abstract
The present study demonstrates the effects of adrenalectomy and subcutaneously administered corticosterone on N-methyl-d-aspartate-
induced neurodegeneration in the cholinergic magnocellular basal nucleus of the rat. NMDA was unilaterally injected into the nucleus
basalis at different plasma corticosterone concentrations in adrenalectomized rats, in adrenalectomized animals with subcutaneously
implanted cholesterol-corticosterone pellets containing 25% or 100% corticosterone, and in sham-adrenalectomized controls. The
neurotoxic impact of the NMDA injection in the various experimental groups was assessed by the loss of cholinergic fibers stained with
acetylcholinesterase histochemistry in the parietal neocortex. Reactive cortical astrocytes as a result of the treatments were detected by
glial fibrillary acidic protein immunohistochemistry. Measurements of the densities of astrocytes and cholinergic fibers at the injected
side of the brain were carried out by image analysis.
Adrenalectomy significantly potentiated the NMDA-induced neurodegeneration by 50%, while chronic administration of corticosterone
significantly attenuated the NMDA-neurotoxicity in a dose-dependent manner. Compared to the ADX group, 25% corticosterone application
reduced the NMDA damage by 37%, whereas the 100% corticosterone pellet dimished NMDA neurotoxicity by 75%. Both ADX and
ADX+corticosterone implantation enhanced the NMDA-induced GFAP immunoreactivity. The increase of GFAP immunoreactivity was
most pronounced in the adrenalectomized rats supplied with the 100% corticosterone pellets.
The results demonstrate that corticosterone exerts a potent neuroprotective effect on NMDA-induced neurotoxicity in the magnocellular
nucleus basalis. The activated astroglia suggest that astrocytes may contribute to the benefical effect of corticosterone in the neuroprotec-
tive mechanisms against excitotoxic neuronal injury.
Corticosteroids (cortisol in human, corticosterone in rats) are other hand, the same steroids can cause neuronal damage and
increase the vulnerability of nerve cells in the hippocampus tosecreted from the adrenal cortex in particularly high concentra-
tions as a result of stressful experiences. Besides the peripheral metabolic insults (10), while specific eects of corticosteroids on
cholinergic fiber degeneration by cholinotoxins were described bysites of action, the brain is a major target organ for these
hormones. Due to their lipophylic nature corticoids (CORT) Hortangl et al. (11).
Chronic stress and stress evoked levels of corticosterone mayeasily pass through the blood–brain barrier and bind to intracellu-
lar mineralocorticoid (MRs) and glucocorticoid receptors (GRs) cause shrinkage and atrophy of apical dendrites in the CA3
region in the hippocampus of rat and tree shrew (12, 13), whilein neurons and glia as was shown by radioligand binding studies
(1, 2) and immunohistochemistry (3, 4). The functions of gluco- chronic exposure to cortisol reportedly induces damage to CA2
and CA3 neurons in monkey hippocampus (14). The neurotoxiccorticoids on brain processes are multifold, ranging from develop-
mental eects to influencing complex emotional and cognitive mechanisms involved may include direct eects of glucocorticoids
via intracellular receptors. However, it has been found thatprocesses (5–7). The impact of particularly high levels of gluco-
corticoids appear to be paradoxical, since both neuroprotective corticoids can increase the extracellular concentration of glutam-
ate (15–17), possibly via inhibition of glutamate uptake byand neurodegenerative eects have been reported.
Glucocorticoids (GC ) may exert a neurotrophic, protective astrocytes (18), leading to neuronal excitotoxicity and subsequent
neuronal injury. Glucocorticoids are also able to increase therole in the hippocampus (8). It was also demonstrated more
recently that glucocorticoids are essential for the development of Ca2+ influx via voltage gated Ca2+ channels further enhancing
the Ca2+ mediated neurotoxic eects (19).the rat cerebral cortex as these hormones play a role in the
control of cellular dierentiation and maturation (9). On the In view of the growing evidence for a mechanistic link between
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the disregulation of the intracellular Ca2+ homeostasis and the neurotoxic eect of the 60 nmol NMDA injections in the
MBN, in which case the percentage of cholinergic fiber loss inglucocorticoid mediated neurotoxicity, it became of interest to
investigate the eect of glucocorticoids on Ca2+ induced neurod- the somatosensory cortex was significantly increased (P<0.01)
from 43.8 to 66.0±1.7% (Fig. 2). The increased vulnerability toegeneration in the brain. Furthermore, most of the studies on the
eect of glucocorticoids on viability of nerve cells were carried NMDA neurotoxicity after adrenalectomy was prevented by
implantation of 25% corticosterone pellets in the ADX rats. Theout on the hippocampus, while little is known of the glucocort-
icoid-induced alterations of the neuronal survival in other brain NMDA injections in the ADX+25% CORT group resulted in a
fiber loss of 41.8±1.5%, which was not significantly dierentregions. Such impact of corticosteroids appears to be particularly
relevant to the proposed role of steroids in the pathogenesis of from the fiber reduction caused by the NMDA injections in the
sham animals. NMDA-induced fiber loss was strikingly attenu-Alzheimer’s disease (20, 21). In this view a deranged regulation
of glucocorticoid balance and chronic exposure to high GC levels ated by implantation of 100% corticosterone pellets in ADX rats.
In this experimental group the cortical fiber reduction afterwould accelerate the aging process of nerve cells and form a risk
factor of neuronal damage in Alzheimer’s disease (21). In this NMDA injection was only 16.5±2.9%, which was significantly
less compared to the NMDA damage in the ADX and controlrespect the vulnerability of cholinergic neurons of the basal
forebrain to neurodegenerative mechanisms and GC is of special groups (P<0.01). Comparing fiber densities in the cortex of the
non-lesioned control sides showed that ADX and the implantationinterest, because of the reported loss of this particular cellgroup
in Alzheimer’s disease (22–24). of pellets with dierent corticosterone concentrations had no
eect on the normal AChE fiber density (data not shown).In the present study we investigated the impact of corticosterone
manipulation on neuronal degeneration of cholinergic cells in the NMDA injection into MBN evoked a conspicuous increase of
GFAP-immunoreactivity in the injection area in the basal fore-magnocellular nucleus basalis (MBN ) induced by the glutamate
analog N-methyl--aspartate (NMDA). In previous reports it brain when compared to GFAP-ir in the sham-ADX/vehicle
injected animals. However, the GFAP-ir expression did not dierwas demonstrated that injections of glutamate analogs like
NMDA, AMPA and ibotenic acid in the MBN region caused between the groups that received an NMDA injection (sham-
ADX, ADX, ADX+25% CORT and ADX+100% CORT ).cholinergic cell loss in the injection area and dose-dependently
reduced the cholinergic fiber density in the somatosensory cortex Figure 3 shows the density of the GFAP expression in the
neocortex, which significantly increased in the ADX animalsvia Ca2+ mediated neurotoxic processes (25–28).
An advantage of this neurodegeneration model is the easy and (320±38.3%) compared to sham-ADX animals (37.4±10.9%)
(P<0.01). Cortical GFAP density values of the ADX+25%reliable quantification of the eect of the cellular lesion, since in
contrast to cell loss, their fiber projections can precisely be CORT (307.0±41.8%) and ADX+100% CORT (634.5±33.5%)
groups were significantly dierent from sham-ADX rats (P<0.01;measured by image analysis while omitting the hazards of cell
counts (29). The same neurotoxicological model was used in the Fig. 4). The GFAP reaction in the ADX+100% CORT group
was even significantly larger than the GFAP response of thepresent study injecting NMDA into MBN of rats at dierent
corticosterone plasma concentrations. The neurodegenerative ADX+25% CORT rats. Adrenalectomy and the corticosterone
implantation had no visible eects on GFAP expression in theexperiments were performed in sham-operated controls, in adrena-
lectomized (ADX ) animals and in ADX rats supplied with 25% cortex at the nonlesioned control side of the brain.
(ADX+25% CORT) or 100% (ADX+100% CORT) corticos-
terone pellets. The neurotoxic eects of the NMDA infusions in Discussion
the MBN after the corticosterone manipulations were established
by measuring cholinergic fiber densities in the cortex visualized The present experiments demonstrate that adrenalectomy
increases the vulnerability of cholinergic neurons of the magnocel-by acetylcholinesterase (AChE) histochemistry. In order to evalu-
ate the putative role of an astrocytic reaction in these experiments lular nucleus basalis to excitotoxic neuronal injury. This potenti-
ation of NMDA-induced cell loss in the MBN was absent inthe major intermediate filament protein of astrocytes, glial fib-
rillary acidic protein (GFAP), was visualized by immuno- adrenalectomized rats in which the plasma corticosterone level
was maintained at low serum levels of 38 nM by a 25% corticos-cytochemistry.
terone pellet implantation. ADX and a 100% cortocosterone
pellet leading to a serum concentration of 150 nM even producedResults
a significant reduction of excitotoxic cell damage in the MBN.
Accordingly, the NMDA-induced cortical GFAP expression wasIn the adrenalectomized animals the plasma corticosterone con-
centrations were below the detection levels indicating successful enhanced in adrenalectomized rats that had no corticosterone
pellets and adrenalectomized rats implanted with corticosteroneremoval of the adrenals. The corticosterone level was
38±8 nM(1.32±0.3 mg/dl ) in the ADX+25% CORT animals pellets leading to basal or higher CORT serum levels.
and reached concentrations of 150±16 nM(5.2±0.55 mg/dl ) in
Corticosterone, neurodegeneration and neuroprotectionthe ADX+100% CORT rats.
The sham-ADX rats that received a vehicle injection into the Corticosterone acting as a neuroprotective hormone against cyto-
toxic neurodegeneration appears to be in contrast to the reportednucleus basalis only showed a minor damage to MBN neurons
expressed as a reduction of 4±2.5% AChE-positive fibers in the eects of adrenalectomy and exposure to high CORT levels on
cell damage in the hippocampus induced by neurotoxins or thatipsilateral neocortex. In the sham-ADX rats, the infusion of
60 nmol of NMDA in the MBN complex resulted in a profound occurring during stroke. Under such conditions in the rat, ADX
decreases cell damage in the CA1 and CA3 regions of thedecrease of 43.8±2.9% of AChE fibers in the neocortex of the
injected hemisphere (Figs 1 and 2). Adrenalectomy potentiated hippocampus, whereas prolonged elevation to very high plasma
© 1997 Blackwell Science Ltd, Journal of Neuroendocrinology, 9, 713–720
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F. 1. Eects of N-methyl--aspartate (NMDA) infusion into the rat magnocellular nucleus basalis (MBN ) on cholinergic, acetylcholinesterase-
positive, innervation of the rat somatosensory cortex in combination with adrenalectomy and 25% or 100% chronic corticosterone implantation. ()
depicts parietal cortical section of an NMDA-lesioned animal, () that of an adrenalectomized rat with subsequent NMDA infusion into the MBN,
() and ( ) represent those of 25% or 100% corticosterone-implanted animals after NMDA lesions, respectively. Note the dramatic loss of cholinergic
inervation after adrenalectomy in combination with acute NMDA injection ( ), whereas chronic corticosterone administration dose-dependently
prevented NMDA-induced loss of cortical cholinergic innervation ( and ). Representative photomicrographs depict layer V of the posterior
somatosensory cortex. All panels have the same magnification, scale bar=100 mm.
CORT levels can create a condition that increases the vulnerability exposure including derangement of calcium homeostasis, inhibi-
tion of glucose uptake and neurotrophin mobilization, and dis-of nerve cells to neurodegenerative processes as in aging, ischemia
and possibly other neurodegenerative diseases (14, 20, 21, 30, turbance of ionic balance over the neuronal membrane (32).
Major factors that account for the dierences between reported31). Several probably interacting mechanisms have been proposed
to explain the neurodegenerative eects of high glucocorticoid neurodegenerative action of high GC concentrations and the
© 1997 Blackwell Science Ltd, Journal of Neuroendocrinology, 9, 713–720
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F. 2. Eect of ADX and corticosterone pellet implantation on percent- F. 4. Eect of ADX and corticosterone pellet implantation on percent-
ages of area densities of cholinergic fiber loss in the cortex after unilateral ages of area densities of GFAP expression in the cortex after unilateral
NMDA injection in the MBN (mean±SEM, *P<0.005). The area NMDA injection in the MBN (mean±SEM, *P<0.005). The area
densities of acetylcholine fibers at injected side were expressed as a densities of GFAP immunoreactivity at injected side were expressed as a
percentage of area densities at control side for each individual. percentage of area densities at control side for each individual.
F. 3. Enhancement of glial-fibrillary acidic protein (GFAP) immunoreactivity (ir) after chronic corticosterone implantation and subsequent N-methyl-
-aspartate (NMDA) lesions in the magnocellular basal nucleus of rats (MBN ). () depicts a parietal cortical section of an NMDA-lesioned animal,
while ( and ) those of 25% or 100% corticosterone-implanted animals after NMDA lesions, respectively. Note the graded induction of GFAP-ir in
astrocytes as the result of chronic 25% or 100% corticosterone treatment. All panels show layer V of the rat parietal cortex and have the same
magnification. Scale bar=100mm.
neuroprotective eects of GC observed in our experiments are regions. Likewise, Krugers et al. (34), three days after adrenalec-
tomy, only observed degenerative changes that were limited tothe brain region involved, the time course and duration of
treatments and the CORT concentrations used. Even within the the dentate gyrus. Several other reports suggest that neuronal
injury following stress and corticosterone administration is not ahippocampus, CORT strongly enhanced ischemia-induced brain
damage in CA1 but had only minor eects on the dentate gyrus general phenomenon and depends on the type and age of the
species under study and the duration of the treatment. Peripheral(31). Conrad & Roy (33) showed long-term degenerative eects
of ADX in the rat dentate gyrus but not in the ammon’s horn administration of corticosterone for 8 weeks in young Long Evans
© 1997 Blackwell Science Ltd, Journal of Neuroendocrinology, 9, 713–720
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rats did not aect the hippocampal cell structure (35), while It should be realized, however, that the putative neuroprotective
potential of GC against excititoxic cell damage cannot only beanxiety stress for 6 months in young adult Fisher 344 rats failed
to cause neuronal cell loss of hippocampal CA1 pyramidal cells explained on GC eects on locally applied NMDA in the nucleus
basalis. GC manipulation not only aects the MBN neurons but(36). As argued above, neurotoxic eects of glucocorticoids were
demonstrated mainly in the CA1 area of the hippocampus and has also considerable influence on the cortical regions that receive
the MBN projections, as is indicated by the cortical glia responsenot in other brain regions. Also in vitro experiments indicate that
glucocorticoids exacerbate kainic acid-induced neuronal damage of GFAP expression. In this respect the changes in the reductions
of cholinergic fiber innervation after NMDA injections in thein cultures of hippocampal neurons but not of cerebellar or
hypothalamic cells (37). MBN might be influenced as well by CORT eects on degenerat-
ing axonal projections in the cortex.It should also be noted that very low CORT levels that occur
after adrenalectomy in the present experiments exacerbate the Besides changes in ionic conductance several additional syner-
gistic mechanisms may be involved in the neuroprotective eectneurotoxic action of NMDA infusions in the MBN region. In
that sense the neurodegenerative impact of very low CORT levels of high concentrations of corticosterone against the NMDA-
induced cell death. Glucocorticoid receptor activation promotescorroborates the findings of Van Lookeren Campagne et al. (38)
who reported massive NMDA induced apoptotic cell death in the synthesis of the protein lipocortin-1 (47), which can act as a
neuroprotective agent in ischemic insults (48) and equally wellearly postnatal rat brain, a period of life with very low CORT
levels. Furthermore, in our experiments no conditions were inhibits cell damage induced by NMDA receptor agonists (49).
Furthermore, GC can potently inhibit glucose transport and thusinvestigated where CORT concentrations reached levels that are
reported after prolonged chronic stress. the supply of energy to the nerve cell, which becomes of particular
importance when the nerve cell is under threat of overload byIt may well be concluded that the eects of glucocorticoids
depend on the hormone concentration and on the anatomical Ca2+ as is the case after NMDA exposure. However, the inhibit-
ory eect of GC on glucose transport was only demonstrated inregion, which may be the consequence of the presence or absence
of the two corticosteroid receptor types and the changed balance cultured hippocampal neurons (32).
A third neuroprotective mechanism stimulated by CORTbetween MR and GR (39).
appears to be the production of neurotrophic factors of which
Possible mechanisms of neuroprotection by glucocorticoids nerve growth factor (NGF) is highly relevant in view of the
specific localization of its receptors on cholinergic basal forebrainAn obvious conclusion from the extensive literature on this
subject is that complex interacting mechanisms underly the impact neurons. Previous in situ hybridization studies revealed that
systemic corticosterone administration elicited a temporal induc-of glucocorticoids on neuronal survival. Glucocorticoids exert a
profound influence on ionic conductances as was demonstrated tion of basic fibroblast growth factor (bFGF ) and NGF mRNA
in the cerebral cortex (50). Conversely, adrenalectomy leads to ain a number of electrophysiological studies notably on hippocam-
pal pyramidal cells (40). Low levels of corticosteroids result in decreased expression of neurotrophins including NGF, which is
directly associated with attenuated neuronal survival in ischemicreductions of calcium currents and reduced sensitivity to several
transmitters, mediated by CORT eects on MRs (40, 41), which conditions and hypoglycemic stress (51, 52). The association of
NGF and its receptor on cholinergic neurons is obvious. Selectivewas partly confirmed recently in transgenic mice lacking GRs
(42). In contrast, CORT activation of the GR enhances calcium cholinergic cell destruction can be induced by immunotoxins that
are directly acting on the NGF receptor (53), whereas nerveinflux and reduces the eects of excitatory amino acid stimulation
(19). It should be noted, however, that simultaneous activation growth factor can be protective or regenerative to excitotoxic
MBN lesions (54). Interestingly, intracellular elevation of calciumof both MR and GR is essential to induce large Ca2+ currents
(41). As a result of such CORT-evoked changes in calcium concentrations by ischemia and NMDA channel stimulation by
glutamate, which is thought to underlie ischemic cell damage, canconductance, high CORT levels enlarge after hyperpolarization
of pyramidal cells (19, 40), which probably renders these cells be dose-dependently prevented by neurotrophins like NGF (55).
However, we are only starting to understand the complex inter-less sensitive to excitatory amino acids (19). It may be clear from
these observations that CORT eects will be highly dependent actions of glucocorticoids and the temporal and GC concentra-
tion-dependent regulation of neurotrophin expression and theon the presence of MRs and GRs. Presence of GR but probably
not MR in MBN neurons (43) may thus yield decreased sensitivity neurotrophin receptor linked signal transduction pathways.
to transmitters like glutamate and in this way antagonize the
Corticosterone and GFAP expressionprocess of NMDA-triggered degeneration of MBN neurons.
A predominant role for GRs in the neuroprotective eects of The present experiment revealed that all NMDA injected rats
showed abundant amounts of GFAP immunoreactive astrogliarelatively high CORT titers against NMDA-induced neurotoxicity
is also supported by dierential CORT binding dependent on the in the area surrounding the NMDA infusion site in the MBN
probably as a result of mechanical and chemical injury inducedhormone concentration. Administration of 25% CORT pellets
results in a saturation of the MR and minor occupation of the by excitotoxin. The expression of GFAP in the neocortex was
only slightly enhanced as a result of the MBN lesion andGR (44, 45). Implantation of 100% CORT pellets, which pro-
duced a significant neuroprotective condition, leads to a half subsequent cortical cholinergic fiber loss. However, adrenalec-
tomy followed by the MBN lesion strongly increased GFAPmaximal occupation of the GRs (45), suggesting a GR mediated
protective mechanism. Similar mechanisms of CORT action were immunoreactivity in the cortex of the lesioned hemisphere.
The impact of ADX and corticosterone on astrocyte activationreported by Zoli et al. (46), who found significant antagonistic
eects of glucocorticoids against glutamate neurotoxicity in the were previously studied by O’Callaghan et al. (56). These authors
reported an increase of GFAP positive astrocytes and GFAParcuate nucleus, an area highly enriched in GRs.
© 1997 Blackwell Science Ltd, Journal of Neuroendocrinology, 9, 713–720
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was raised in rabbit against corticosterone-carboxymethyloximine-BSA.mRNA in the neocortex after ADX, while glucocorticoids sup-
125I-labelled corticosterone-carboxymethyloximine-tyrosine-methylesterpressed the level of GFAP protein and mRNA. Such results were
was used as the tracer. The interference of plasma transcortin was
not confirmed in the present study where we failed to find evidence eliminated by inactivating transcortin at low pH. The sensitivity of the
for changes in GFAP expression in the neocortex at the control assay was 0.1 pmol. Intra- and interassay variations were 6.4% and 23.8%
respectively.side of the brain. This implicates that the eects of ADX and
corticosterone on GFAP-ir were most likely mediated by mechan-
isms associated with the NMDA exposure to MBN neurons and Tissue processing
the subsequent degeneration of cortical cholinergic fibers. The Fixation of the brains was carried out by transcardial perfusion with
300 ml cold fixative composed of 4% paraformaldehyde in 0.1 M phos-functions of GFAP are not entirely clear. The protein appears to
phate buer (PB, pH 7.4) at 27 ml/min, which was preceded by a shortbe essential for maintenance of the structural integrity (57), while
prerinse of heparinized saline. The brains were removed from the skullGFAP positive astrocytes have the capacity to support the
and stored for 3 h in the fixative followed by 48 h storage at 4 °C in 0.1
neurons during neurological insults. Since GFAP-ir cells were phosphate buered saline (PBS) with 30% sucrose for cryoprotection.
only observed in the neocortex of the lesioned side of the brain Subsequently the brains were coronally sectioned on a cryostat microtome
at a thickness of 25 mm and series of adjacent sections collected in PB forthis suggests that the observed GFAP increase can only be
parallel staining for cholinergic fibers by AChE and glia activation byattributed to the neurodegenerative events that occur as a result
GFAP immunoreactivity.of the cholinergic cell lesion.
The present results provide evidence that glucocorticoids can
Histochemistryexert neuroprotective eects cholinergic cells in the MBN against
AChE staining was performed to visualize the intact cholinergic fibers.cell death evoked by excitotoxic neurodegenerative mechanisms.
Free floating brain sections were postfixed by overnight immersion in aAdrenalectomy and suppletion of corticosterone potentiate astro-
2.5% glutaraldehyde solution in 0.1M PB at 4 °C. The AChE staining
cyte activation in the areas where the cholinergic fiber undergo was carried out according to Hedreen et al. (61) using a AgNO4degeneration. These findings indicate that corticosterone can be intensification procedure.
beneficial for neuroprotective and possibly neuroregenerative
processes after brain insults involving damage to the basal fore- Immunocytochemistry
brain cholinergic cell system. The functional consequences of this The tissue sections were rinsed in 0.01 M PBS (pH 7.4) and preincubated
neuroprotective action, and its relation to the CORT-related for 15 min with 0.1% H2O2. Next the sections were rinsed for 30 min with5% normal sheep serum (NSS ) and incubated for 24 h at 4 °C with thealteration in hippocampal neuronal survival remain to be
first antibody (monoclonal anti-GFAP IgG, Amersham, 15200). 5% NSSdetermined.
and 0.2% Triton-X-100 were added to the PBS in all incubation and
rinsing steps. The sections were rinsed and exposed for 2 h to biotinylated
sheep anti-mouse IgG(15200, Amersham) and for 1.5 h to HRP-streptavi-Materials and methods
din (15200, Zymed). The HRP label was visualized by reacting with 3,3∞-
Animals diaminobenzidine(60 mg/100ml Tris-HCl buer, pH 7.6) and 0.01%
H2O2. The reaction was stopped by rinsing in Tris buer.Young adult male Wistar rats (weighing 300–350 g) were used for all
experiments bred in our own facilities under SPF conditions. The animals
were housed at 24 °C and 55–75% humidity with light-dark cycles Quantifications
(12/12 h) beginning at 06.00 h. Animals had standard rat chow and tap
Quantification of AChE fiber- and GFAP cell densities was performed inwater available ad libitum. All procedures in this study were approved by
the MBN projection areas in the parietal somatosensory cortex using anthe Committee on Animal Bio-Ethics of the University of Groningen.
automatic image analysis system (IBAS ) as described in detail in a
Surgeries previous report (62 ). Briefly, in each experimental animal four sections
of the parietal cortex with intervals of 200 mm were measured and theAll surgeries were carried out under deep anaesthesia with sodium
values averaged. The area densities of the cholinergic fibers were measuredpentobarbital (30 mg/kg, i.p.) and Hypnorm (Janssen, 0.4 mg/kg, i.m.).
in layer V of the ipsilateral and contralateral somatosensory cortex.Adrenalectomy (ADX ) was performed using a dorsal approach. During
Because of the strictly unilateral organization of MBN projection, thethe same surgery corticosteroid-cholesterol pellets (crystalline CORT,
contralateral intact side served as a control within each individual subjectSigma, St. Louis, MO, USA) weighing approximately 200 mg were
and the fiber reduction calculated from the fiber densities at the injectedinserted subcutaneously 2 cm caudal to the skin incision made for the
site as a percentage of the densities of the intact control side.adrenalectomies (58 ). The animals were divided into four groups: (1)
Measurements of cholinergic fiber reductions were limited to layer V sincesham-adrenalectomized control rats implanted with pellets consisting of
this cortical layer in the neocortex normally contains the highest density100% cholesterol (n=12); (2) ADX rats (n=6); (3) ADX rats with
of innervation. Besides, layer V can easily be delineated from the adjacentpellets of 75% cholesterol-25% corticosterone (n=6); and (4) ADX
layers IV and VI and thus yield a reproducible and reliable region foranimals provided with a 100% corticosterone pellet (n=6 ).
quantitative measurements. With the magnification used, a column widthAfter four days the animals were anesthetized with halothane, mounted
of 1 mm was measured. The densities of GFAP-positive astrocytes wereand 60 nmol NMDA (Sigma) in 1 ml 0.1M phosphate buered saline
(PBS, pH7.4) was stereotactically injected into the right MBN at the measured in an area of 1.6 mm width of layers II, III, IV and V of the
coordinates (from bregma and dura: A:-1.8, L:3.2, V:7) according to the same somatosensory cortex regions of both hemispheres. Layers II-V
atlas of Paxinos and Watson (59). Half of the sham-ADX group was were measured since changes in GFAP expression were limited to these
injected with vehicle alone (n=6 ). The injection procedure was described cortical layers. Area densities of astrocytes at injection side were expressed
in detail elsewhere (29). After the NMDA injection the animals survived as a percentage of area densities at the non-lesioned control side for each
for 11 days until sacrifice and histological processing. individual.
Hormone measurement
Statistical analysisBefore perfusion blood samples were taken from all animals by cardiac
Data were expressed as the mean±SEM. The Mann–Whitney nonpara-puncture. The samples were collected in pre-chilled tubes containing 20%
metric test was used with downward adjustment of a level with theK-EDTA, centrifuged and the plasma stored at -20 °C until hormone
Bonferoni t method for calculating significant dierences between themeasurement. Plasma corticosterone was measured by radioimmunassay
(RIA) without extraction as described previously (60). The antiserum groups (P<0.05).
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